P2y(12) inhibitor monotherapy after 1–3 months dual antiplatelet therapy in patients with coronary artery disease and chronic kidney disease undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials

INTRODUCTION: In patients with coronary artery disease (CAD) and chronic kidney disease (CKD) undergoing percutaneous coronary intervention (PCI), whether short-term dual antiplatelet therapy (DAPT) followed by P2Y(12) inhibitors confers benefits compared with standard DAPT remains unclear. This stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yanqiao, Pan, Deng, Bai, Ruina, Luo, Jinwen, Tan, Yu, Duan, Wenhui, Shi, Dazhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357506/
https://www.ncbi.nlm.nih.gov/pubmed/37485257
http://dx.doi.org/10.3389/fcvm.2023.1197161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357506/
https://www.ncbi.nlm.nih.gov/pubmed/37485257
http://dx.doi.org/10.3389/fcvm.2023.1197161

Ejemplares similares